These findings are consistent with an association between ENT2 upregulation and advanced stages of several types of cancers, such as mantle cell lymphoma, hepatocellular carcinoma, and colorectal cancer [31]. This evidence concerns the gene SLC29A2 and hepatocellular carcinoma.